Answers are grounded in this paper and cite their sources.
Results obtained so far suggest that radiolabeled rhTSH might be a promising radiopharmaceutical for diagnosis and follow-up of DTC.
No takes yet. Share an insight, caveat, or question.
Corsetti et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: